SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-045815
Filing Date
2013-08-14
Accepted
2013-08-14 15:20:36
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v350819_10q.htm 10-Q 641728
2 EXHIBIT 31.1 v350819_ex31-1.htm EX-31.1 9601
3 EXHIBIT 32.1 v350819_ex32-1.htm EX-32.1 5197
  Complete submission text file 0001144204-13-045815.txt   3595229

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgrx-20130630.xml EX-101.INS 307174
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20130630.xsd EX-101.SCH 23405
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20130630_cal.xml EX-101.CAL 19908
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20130630_def.xml EX-101.DEF 115205
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20130630_lab.xml EX-101.LAB 157310
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20130630_pre.xml EX-101.PRE 143987
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 131037480
SIC: 2834 Pharmaceutical Preparations